TabletCaída del Cabello
Finasteride tablets
The classic DHT blocker.
$99.00
Finasteride 1 mg is an FDA-approved medication for male-pattern hair loss that lowers DHT, the hormone linked to follicle shrinkage.
Choose your strength
- Licensed U.S. providers
- Licensed U.S. pharmacies
- Discreet delivery
1 mg
30 tablets
FDA-approved for hair loss
About this treatment
What is Finasteride tablets?
Finasteride 1 mg is an FDA-approved medication for male-pattern hair loss that lowers DHT, the hormone linked to follicle shrinkage.
How it fits your routine
One tablet daily.
Cómo funciona

Haga su evaluación
Responda unas preguntas rápidas, encuentre el tratamiento que se adapta a sus objetivos y realice su compra en minutos.

Cuestionario inicial y revisión del proveedor
Complete un breve cuestionario de salud. Un proveedor con licencia en EE. UU. lo revisa y decide si su tratamiento es adecuado para usted.

Entrega discreta
Si se le receta, su medicamento se envía desde una farmacia con licencia en EE. UU. directamente a su puerta en un empaque discreto.
Why NakedEnvy
Care that feels personal.
Provider-led
A licensed U.S. provider reviews your health information before anything is prescribed.
Pharmacy-made
Medications are prepared and dispensed by licensed U.S. pharmacies.
Apoyo continuo
Questions about your plan? Message our care team any time.
FAQ
Questions, answered.
Is it for women?
Finasteride is generally prescribed to men.
What about side effects?
Your provider will review possible side effects with you.
Is a prescription guaranteed?
No. A licensed provider reviews your intake and decides independently whether this treatment is appropriate for you.
How is my order shipped?
If prescribed, your medication is dispensed by a licensed U.S. pharmacy and shipped to your door in discreet packaging.
Ready to see if Finasteride tablets is right for you?
Los medicamentos compuestos no están aprobados por la FDA. Se requiere receta médica. Un proveedor con licencia determina la elegibilidad. Los resultados individuales varían.
